1
|
Álvarez Porebski PW, Gyssels E, Madder A, Lynen F. Hyphenation of a Deoxyribonuclease I immobilized enzyme reactor with liquid chromatography for the online stability evaluation of oligonucleotides. J Chromatogr A 2015; 1422:18-26. [PMID: 26515385 DOI: 10.1016/j.chroma.2015.10.015] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2015] [Revised: 10/05/2015] [Accepted: 10/08/2015] [Indexed: 10/22/2022]
Abstract
The stability of antisense oligonucleotides (ONs) toward nucleases is a key aspect for their possible implementation as therapeutic agents. Typically, ON stability studies are performed off-line, where the ONs are incubated with nucleases in solution, followed by their analysis. The problematics of off-line processing render the detailed comparison of relative ON stability quite challenging. Therefore, the development of an online platform based on an immobilized enzyme reactor (IMER) coupled to liquid chromatography (LC) was developed as an alternative for improved ON stability testing. More in detail, Deoxyribonuclease I (DNase I) was immobilized on epoxy-silica particles of different pore sizes and packed into a column for the construction of an IMER. Subsequently, the hyphenation of the IMER with ion-pair chromatography (IPC) and ion-exchange chromatography (IEC) was evaluated, leading to the successful development of two online methodologies: IMER-IPC and IMER-IEC. More specifically, natural and modified DNA and RNA oligonucleotides were used for testing the performance of the methodologies. Both methodologies proved to be simple, automatable, fast and highly reproducible for the quantitative and qualitative evaluation of ON degradation. In addition, the extended IMER life time in combination with a more straightforward control of the reaction kinetics substantiate the applicability of the IMER-LC platform for ON stability tests and its implementation in routine and research laboratories.
Collapse
Affiliation(s)
- Piotr Wiktor Álvarez Porebski
- Separation Science Group, Department of Organic and Macromolecular Chemistry, Universiteit Gent, Krijgslaan 281 S4-bis, 9000 Gent, Belgium.
| | - Ellen Gyssels
- Organic and Biomimetic Chemistry Research Group, Department of Organic and Macromolecular Chemistry, Universiteit Gent, Krijgslaan 281 S4-bis, 9000 Gent, Belgium.
| | - Annemieke Madder
- Organic and Biomimetic Chemistry Research Group, Department of Organic and Macromolecular Chemistry, Universiteit Gent, Krijgslaan 281 S4-bis, 9000 Gent, Belgium.
| | - Frederic Lynen
- Separation Science Group, Department of Organic and Macromolecular Chemistry, Universiteit Gent, Krijgslaan 281 S4-bis, 9000 Gent, Belgium.
| |
Collapse
|
4
|
Shinozuka K, Matsumoto N, Suzuki H, Moriguchi T, Sawai H. Alternate stranded triplex formation of chimeric DNA composed of tandem alpha- and beta-anomeric strands. Chem Commun (Camb) 2002:2712-3. [PMID: 12510312 DOI: 10.1039/b208793f] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
A chimeric oligoDNA composed of a natural beta-anomeric oligonucleotide portion and an unnatural alpha-anomeric oligonucleotide portion forms an alternate stranded triplex possessing enhanced thermal stability compared to the triplexes composed of the parental oligomers.
Collapse
Affiliation(s)
- Kazuo Shinozuka
- Department of Chemistry, Faculty of Engineering, Gunma University, 1-5-1 Tenjin-cho, Kiryu 376-8515, Japan.
| | | | | | | | | |
Collapse
|
5
|
Tan TM, Kalisch BW, van de Sande JH, Ting RC, Tan YH. Biologic activity of oligonucleotides with polarity and anomeric center reversal. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT 1998; 8:95-101. [PMID: 9593047 DOI: 10.1089/oli.1.1998.8.95] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Human papillomavirus (HPV) type 16 E6 and E7 inactivate the tumor suppressors p53 and pRB, respectively. Both viral oncoproteins play important roles in maintaining the transformed phenotype of cells. In this study, we examine the effects of antisense oligodeoxynucleotides with polarity and anomeric center reversal (alpha/beta-ODNs). ODNs of the general structure 5'alphaN3'3'NNN5'5'alphaN3'3'NNNN5'5'alphaN3+ ++'3'N5' were synthesized using phosphoramidite DNA chemistry. These alpha/beta-ODNs were complementary in sequence to regions flanking the start codons of HPV type 16 E6 and E7 genes. The anti-HPV type 16 alpha/beta-ODNs were able to form stable duplexes with their complementary RNA, which then serve as substrates for RNase H hydrolysis. Anti-HPV type 16 alpha/beta-ODNs also specifically inhibited the growth of two cervical carcinoma cell lines, CaSki and SiHa, both of which harbor HPV type 16 DNA. A decrease in E7 protein expression was also observed. Injection of nude mice with SiHa cells induces tumors. Treatment of these tumor-bearing mice with anti-HPV type 16 alpha/beta-ODNs led to substantially smaller tumors. These results show that alpha/beta-ODNs can exert antisense activities both in vitro and in vivo on the E6 and E7 genes of HPV type 16.
Collapse
MESH Headings
- Animals
- Carcinoma/pathology
- Carcinoma/therapy
- Cell Division/drug effects
- Codon/genetics
- DNA, Complementary/genetics
- DNA, Viral/genetics
- Female
- Gene Expression Regulation, Viral/drug effects
- Genes, Viral
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Transplantation
- Nucleic Acid Hybridization
- Oligonucleotides, Antisense/chemistry
- Oligonucleotides, Antisense/pharmacology
- Oligonucleotides, Antisense/therapeutic use
- Oncogene Proteins, Viral/biosynthesis
- Oncogene Proteins, Viral/genetics
- Oncogenes
- Papillomaviridae/genetics
- Papillomavirus E7 Proteins
- Papillomavirus Infections/pathology
- RNA, Viral/genetics
- RNA, Viral/metabolism
- Repressor Proteins
- Ribonuclease H/metabolism
- Structure-Activity Relationship
- Tumor Cells, Cultured
- Tumor Virus Infections/pathology
- Uterine Cervical Neoplasms/pathology
- Viral Structural Proteins/genetics
Collapse
Affiliation(s)
- T M Tan
- Institute of Molecular and Cell Biology, National University of Singapore, Singapore
| | | | | | | | | |
Collapse
|
6
|
Tewary HK, Iversen PL. Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part I. In vitro models. J Pharm Biomed Anal 1997; 15:857-73. [PMID: 9160252 DOI: 10.1016/s0731-7085(96)01940-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Part I of this review attempts to bring together all the methods of detection and determination of synthetic oligonucleotides used in in vitro, described in the literature over the past 14 years, in an effort by scientists to use these oligonucleotides as drugs in gene therapy. The in vitro models include cell-free and cell culture systems. Emphasis has been given to the techniques developed for quantification of the input oligonucleotides or their metabolites. The purpose of study, methods of processing, detection and determination techniques such as those based on fluorescence, radiolabeling, high-performance liquid chromatography, gel-electrophoresis and others have been presented.
Collapse
Affiliation(s)
- H K Tewary
- Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198-6260, USA
| | | |
Collapse
|
7
|
Gottikh MB, Fedorova OA, Baud-Demattei MV, Giorgi-Renault S, Bertrand JR, Shabarova ZA, Malvy C. α−β Chimeric Oligonucleotides Form a New Stable “Snail-like” Structure. J Am Chem Soc 1996. [DOI: 10.1021/ja953072c] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- M. B. Gottikh
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| | - O. A. Fedorova
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| | - M.-V. Baud-Demattei
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| | - S. Giorgi-Renault
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| | - J.-R. Bertrand
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| | - Z. A. Shabarova
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| | - C. Malvy
- Contribution from the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 117899 Moscow, Russia, Laboratoire de Chimie Thérapeutique, CNRS URA 1310, Faculte des Sciences Pharmaceutiques et Biologiques Université René Descartes, avenue de l'Observatoire, 75270 Paris Cedex 06, France, and Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
| |
Collapse
|